MR

Murthy Radhakrishna Venkata Subrahmanya Chennubhotla

Active Director Director DIN 08776099
DIN 08776099 First appointment Jan 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Total affiliations 4 Since Jan 2020
Shareholding value •••• Premium profile

About Murthy Radhakrishna Venkata Subrahmanya Chennubhotla

Data last updated:

Murthy Radhakrishna Venkata Subrahmanya Chennubhotla is a Director at Ayurmegha Research Labs Private Limited (since 2022), Additional Director at Pandit View Software Private Limited (since 2020) and Managing Director at Ayurmegha Healthcare Private Limited (since 2020), and holds 1 more current directorship. The companies operate in Healthcare and Information Technology. The 3 current companies with reported revenue have a combined latest revenue of ₹30 Lakh; the largest is Ayurmegha Research Labs Private Limited at ₹29.2 Lakh (FY 2025).

DIN 08776099
Primary Designation Director
Industry Healthcare
First Appointment 07 Jan 2020
Oldest Company Age 25 yrs
Largest company Ayurmegha Research Labs Private Limited · ₹29.2 Lakh (FY 2025)
Combined revenue ₹30 Lakh across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Feb 20222022₹29.2 Lakh (FY 2025)Active
Pandit View Software Private Limited U80302AP2001PTC036777
Additional Director08 May 20202001₹57,822 (FY 2019)Active
Ayurmegha Healthcare Private Limited U51909KA2020PTC131330
Managing Director07 Jan 20202020₹18,820 (FY 2025)Active
Director02 Jun 20242024Active

Board colleagues of Murthy Radhakrishna Venkata Subrahmanya Chennubhotla

Directorship timeline

Open interactive timeline →
Ayurmegha Healthcare Private Limited
Ayurmegha Research Labs Private Limited
Pandit View Software Private Limited
Scorpiosys Consulting (India) Private Limited
Premium access

Shareholding and investment profile for Murthy Radhakrishna Venkata Subrahmanya Chennubhotla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Murthy Radhakrishna Venkata Subrahmanya Chennubhotla

Murthy Radhakrishna Venkata Subrahmanya Chennubhotla currently holds 4 directorships: Ayurmegha Research Labs Private Limited (Director, since 02 Feb 2022, revenue ₹29.2 Lakh (FY 2025)); Pandit View Software Private Limited (Additional Director, since 08 May 2020, revenue ₹57,822 (FY 2019)); Ayurmegha Healthcare Private Limited (Managing Director, since 07 Jan 2020, revenue ₹18,820 (FY 2025)); Scorpiosys Consulting (India) Private Limited (Director, since 02 Jun 2024).

Murthy Radhakrishna Venkata Subrahmanya Chennubhotla was first appointed on 07 Jan 2020 as Managing Director at Ayurmegha Healthcare Private Limited. The most recent appointment on record is 02 Jun 2024 at Scorpiosys Consulting (India) Private Limited.

The 3 current companies of Murthy Radhakrishna Venkata Subrahmanya Chennubhotla that report revenue have a combined latest revenue of ₹30 Lakh: Ayurmegha Research Labs Private Limited ₹29.2 Lakh (FY 2025); Pandit View Software Private Limited ₹57,822 (FY 2019); Ayurmegha Healthcare Private Limited ₹18,820 (FY 2025).

The current boards of Murthy Radhakrishna Venkata Subrahmanya Chennubhotla's companies include Yamini Bhandi Subramanyam (Ayurmegha Research Labs Private Limited), Sridhar Setty Gadam (Pandit View Software Private Limited), Sunitha Tati (Pandit View Software Private Limited), Prem Kumar Bhaskaran (Scorpiosys Consulting (India) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available